Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
4/25/2023
NMPA Issues the Opinions for Improving Review and Approval of Radiopha...
4/25/2023
Xinhua: Centralized VBP Led to 48% Average Insulin Price Cut and Annua...
4/25/2023
Sable Thera and Liuqiang MedTech Enter Licensing Deal for Fat Reducing...
4/25/2023
Drug Licensing as Evidence of Evolution, Diffusion and Catch-up in Eas...
4/25/2023
Despite Strong Year-on-Year Growth in Q1, Licensing Deals Slow in Marc...
4/24/2023
Grand Pharma Buys BlackSwan Vascular For $37.5 Million
4/24/2023
NMPA Issues Announcement for Applicability of ICH Guidelines E19
4/24/2023
NMPA Announces Package Insert Revision of Multiple Drug Products
4/21/2023
NMPA Issues the 2022 Drug Regulatory Statistics Annual Report
4/21/2023
PhIIC: Review of Chinese Rep Hospital Drug Market in 2022
4/21/2023
Drug R&D and Product Registration News Digest April 2023 (3)
4/21/2023
AstraZeneca Oncology R&D Head On China Biotech Innovation - Looking Ag...
4/20/2023
As Competition Heats Up, China PD-(L)1 Inhibitors Seek More Differenti...
4/20/2023
The US Is Relying More on China for Pharmaceuticals — and Vice Versa ...
4/20/2023
Gene Editing: China's New Regulations Contain Concerning Loopholes, Ex...
4/19/2023
Investors See Confidence in China Slowly Back In 2023; Seeking China-J...
4/19/2023
What A US-China Biotech War Would Mean for Hong Kong and the World (SC...
4/19/2023
How Can Phase I Data from Western Medicine Accelerate Drug Development...
4/19/2023
Everest Medicines Enters Strategic Partnership with Shanghai Pharma Su...
4/19/2023
Crystal Pharmatech's CDMO BU Receives China Drug Product Manufacturing...
4/19/2023
U.S. Imposes Sanctions on Two Chinese PharmChem Companies in Action ov...
4/19/2023
China Blessed First Case of Data Export Security Assessment
4/18/2023
SAMR, MPS and NHC Announcement on Adjustment of the Anesthetic and Psy...
4/18/2023
CDE Issues the Procedures for Application and Management of Category I...
4/17/2023
Financing for Chinese Drugmakers Hit a Slump in March (PharmaDJ)
4/14/2023
Impact of Regulatory System Changes on the Availability of Innovative ...
4/14/2023
Chinese Commercial Health Insurance Grew Rapidly Between 2017-2021
4/14/2023
Review of China's Foreign Trade of Medicines and Health Products in 20...
4/14/2023
Novartis Signs Three-Year Deal to Help Product J&J and Legend's Carvy...
4/14/2023
CDE Issues the Technical Guidelines for Clinical Protocol Design of He...
Page:
49
/
719
Total number of articles:
21546
:
[First]
[<<]
[47]
[48]
[49]
[50]
[51]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit